ELV Technical Analysis — 2024-11-11

▲ Bullish
Price at call $426.86
Published 2024-11-11
Crystal Vision AI · Technical Analysis

Elevance Health, Inc. (ELV)

Current Price: $426.86 (as of November 11, 2024)


ELV is currently exhibiting a recovery phase after recent bearish movements, closing at $426.86 on November 11, 2024. The stock is showing signs of reversal after hitting a near-term bottom, as evidenced by recent price action and increasing volume levels.

Moving Averages

The 20-day Simple Moving Average (SMA) at $428.04 is reflecting a downtrend but is in close proximity to the current price, indicating potential resistance if the price continues to rise. The stock remains below the 50-day ($486.59) and 100-day ($509.7) SMAs, reinforcing that the long-term trend is still downward. However, the proximity to the shorter-term SMA suggests that bullish momentum might be building if the price can break above this level and potentially challenge the longer-term averages.

The Exponential Moving Averages (EMAs) show a slightly different picture with the 12-day EMA at $425.62 nearing a convergence with the closing price, while the 26-day EMA remains higher at $443.78. This increasing proximity suggests diminishing bearish pressure and could signal an imminent trend reversal if the shorter EMA crosses above.

Relative Strength Index (RSI)

The RSI is at 39.68, up from previous oversold levels, which were below 30. This increase indicates that selling pressure is easing, and the stock is gaining momentum to potentially enter a neutral zone. The RSI's recovery supports a bullish outlook if it continues to rise above 50, signaling stronger buying interest.

Bollinger Bands

The price is currently just above the lower Bollinger Band at $382.95, with the middle band at $428.04 acting as immediate resistance. Having bounced off the lower band, this suggests a potential upward correction. The wide distance to the upper band at $473.12 points to available upside if bullish conditions prevail, indicating room for volatility and an opportunity for price expansion should the market sentiment shift more positively.

MACD

The MACD line at -18.16 is below the signal line at -22.63, yet the histogram has shown positive figures lately with a reading of 4.47. The recent reduction in the negative spread between MACD and the signal line, alongside the positive histogram movement, suggests waning bearish momentum and a possible bullish crossover in the near term, typically a precursor for a rally.

On Balance Volume (OBV)

The OBV has consistently increased to 4,394,778, which is a strong indication that buying interest is growing, despite some price declines. This suggests that the volume primarily supports the price movements upward, hinting at a potential sustained recovery if the volume continues to build.

Candlestick Patterns

The candlestick pattern on November 6 and November 7 forms a bullish engulfing pattern, which is typically a strong reversal signal. The following days, the stock has managed to maintain higher lows, further indicating that buyers are starting to dominate. This pattern suggests that the recent downward trend may be reversing and that an upward trajectory could be forthcoming, especially if supported by technical indicators aligning bullishly.

Summary & Implications

ELV exhibits signs of a recovery, transitioning from a bearish to a potentially bullish outlook based on technical indicators. The alignment of key indicators, such as rising OBV, improving RSI levels, and narrowing MACD values, suggests that a reversal is likely in play. The recent bullish engulfing candlestick pattern further strengthens this perspective, predicting an upward price trend if these patterns persist.

Short-term traders might consider entering positions above $428, a move which could signal a break from resistance. Long-term traders will watch moving averages closely for more definitive signals of a trend reversal. Stop-loss strategies should be considered around $410 to protect against potential bearish resumption.

Confidence Score: 75%

Crystal Vision provides directional predictions for informational purposes only. This is not financial advice. Past performance does not guarantee future results. Always do your own due diligence before trading.